| Antigen: |
Platelet-derived endothelial
cell growth factor (thymidine phosphorylase); PD-ECGF |
| Relevance: |
PD-ECGF expression is elevated in breast tumours. PD-ECGF is a prognostic factor in colon tumours. |
| Clone: |
PGF 44C |
| Subclass: |
IgG1 |
| Applications: |
Immunoprecipitation, Western blot, Immunohistochemistry (Acetone Fixed, Paraffin embedded, Frozen) |
| Immunogen: |
Full length human protein in E. coli |
| Reactivity: |
Human |
| Species raised in: |
Mouse |
| Fusion partner: |
NS-1 |
| Recommended growth conditions: |
DMEM + 5%FCS |
| References: |
Moghaddam A et al. 1995. Proc. Natl. Acad. Sci. USA. 92(4):998-1002. 
Giatromanolaki A et al. 2003. J. Pathol. 200(2):222-8 |
| Notes: |
Blocks enzyme activity. Positive control: HUVEC cell or breast carcinoma. 55 kDa (reduced). |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
